Stock Analiz

Rentokil Initial PLC RTO

Other Consumer Services · IPO 2022 · data as of November 13, 2026

$23.91Market cap $12.1B
Open the interactive analysis →

Rentokil Initial PLC (RTO) is a consumer discretionary company listed in the US with a market value of about $12.1B. In the twelve months to June 30, 2026 it had revenue of $7.1B and net income of $478M, a net margin of 6.7%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is track record (0/5).

Key numbers: a P/E of 37.4, a price to free cash flow of 17.1, a 5-year average ROIC of 5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 22% below the current price.

Score: 1.4 / 5

Value1/5
Future growth1/5
Track record0/5
Financial health2/5
Shareholder returns3/5

Checks passed

  • P/FCF below 20
  • Profit margin improving
  • Positive free cash flow
  • Interest covered more than 5 times
  • Pays a dividend
  • 20% to 100% of free cash flow returned to shareholders
  • Dividend 3 years in a row

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)37.4
Forward P/E16.3
P/FCF17.1
P/S1.7
P/B2.2
EV/EBITDA12.5
PEG—
Dividend yield2.66%
FCF yield5.9%
Shareholder yield2.7%
Intrinsic value vs. price−22%

Growth and quality

Revenue growth (1 yr)4.4%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)6.7%
ROIC (5-yr avg.)4.7%
Profitable years (of last 10)3
Years paying a dividend3

Financials, last 3 years

Fiscal yearTTM202520242023
Revenue$7.1B$6.9B$6.6B$6.4B
Net income$478M$470M$392M$474M
Free cash flow$707M$764M$649M$709M
EPS (diluted)$0.94$0.93$0.78$0.94
Net margin6.7%6.8%5.9%7.4%
ROIC—3.9%4.9%5.3%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 4 analysts is $30.70, 28% above the current price; targets range from $25.90 to $35.00; the consensus rating is “none”; expected EPS is $1.40 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is Rentokil Initial’s P/E ratio?

About 37.4, based on the last twelve months of diluted earnings per share (forward P/E about 16.3).

Is Rentokil Initial stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 22% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Rentokil Initial pay a dividend?

Yes. The dividend yield is about 2.66%, and it has paid dividends for 3 years in our data.

Is Rentokil Initial a good stock to buy?

We do not give buy or sell advice. Rentokil Initial scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.